A multifactoral analysis of 1452 patients for smoking sensation. An outpatient lab experience.
Smoking habit is held responsible for several respiratory and metabolic diseases. Data from 1452 patients were recorded from our outpatient laboratory. The following parameters were recorded within several follow ups of our patients; smoking habit, respiratory functions, smoking cessation questionnaires, and administered drugs. The treatment administered to smokers throughout the period of inspection seems to also have a significant effect on dependence. In fact, varelicline causes a 50% reduction in smoking dependence in regards to nicotine substitutes (odds ratio: 0.48 (0.31-0,74), p=0.001) so displaying a substantial preponderance on the choice to fight smoking dependence.
1. Internal Medicine Department, ``Theageneio`` Anticancer Hospital, Thessaloniki, Greece. ; 2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Theodora
T
Tsiouda
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Paul
P
Zarogoulidis
3. Department of Food Technology, School of Food Technology and Nutrition, Alexander Technological Educational Institute, Thessaloniki, Greece.
Dimitris
D
Petridis
4. Surgery Department, Private Cabinet, Serres, Greece.
Nikolaos
N
Pezirkianidis
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Ioannis
I
Kioumis
5. Division of Pulmonary and Critical Care Medicine, Johns Hopkins University, Baltimore, U.S.A.
Lonny
L
Yarmus
6. Department of Respiratory Diseases Shanghai Hospital, II Military University Hospital, Shanghai, China.
Haidong
H
Huang
6. Department of Respiratory Diseases Shanghai Hospital, II Military University Hospital, Shanghai, China.
Qiang
Q
Li
7. II Medical Department, General Hospital of Coburg, University of Wuerzburg, Coburg, Germany.
Wolfgang
W
Hohenforst-Schmidt
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Konstantinos
K
Porpodis
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Dionysios
D
Spyratos
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Kosmas
K
Tsakiridis
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Georgia
G
Pitsiou
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Theodoros
T
Kontakiotis
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Paraskevi
P
Argyropoulou
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
George
G
Kyriazis
2. Pulmonary Department-Oncology Unit, ``G. Papanikolaou`` General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Konstantinos
K
Zarogoulidis
Asthma; CAD.; COPD; smoking sensation